Indanyl piperazines as melatonergic MT2 selective agents

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1199-202. doi: 10.1016/s0960-894x(03)00090-8.

Abstract

Optimization of a benzyl piperazine pharmacophore produced N-acyl-4-indanyl-piperazines that bind with high affinity to melatonergic MT(2) receptors. (R)-4-(2,3-dihydro-6-methoxy-1H-inden-1-yl)-N-ethyl-1-piperazine-carboxamide fumarate (13) is a water soluble, selective MT(2) agonist, which produces advances in circadian phase in rats at doses of 1-56 mg/kg that are no different from those of melatonin at 1 mg/kg. Unlike melatonin, 13 produced only weak contractile effects in rat tail artery.

MeSH terms

  • 3T3 Cells
  • Adenylyl Cyclases / metabolism
  • Animals
  • Circadian Rhythm / drug effects
  • Humans
  • In Vitro Techniques
  • Indicators and Reagents
  • Male
  • Mice
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Piperazines / chemical synthesis*
  • Piperazines / metabolism
  • Piperazines / pharmacology*
  • Rats
  • Rats, Long-Evans
  • Receptors, Cell Surface / agonists*
  • Receptors, Cell Surface / metabolism
  • Receptors, Cytoplasmic and Nuclear / agonists*
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Melatonin

Substances

  • Indicators and Reagents
  • Piperazines
  • Receptors, Cell Surface
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Melatonin
  • Adenylyl Cyclases